New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer's disease treatment

Balaji, N., Balachandar, R., Algodayan, S., Lilburn, D. M. L., Fraioli, F., & Bomanji, J. B. (2023, June 1). New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer’s disease treatment. Nuclear Medicine Communications. Wolters Kluwer Health. https://doi.org/10.1097/MNM.0000000000001688